NASDAQ:ARCT - Arcturus Therapeutics News Headlines

Sign in or create an account to add this stock to your watchlist.
$6.45 +0.22 (+3.53 %)
(As of 05/27/2019 06:00 AM ET)
Previous Close$6.45
Today's Range$6.22 - $6.45
52-Week Range$4.11 - $10.00
Volume7,207 shs
Average Volume44,895 shs
Market Capitalization$69.41 million
P/E RatioN/A
Dividend YieldN/A
Beta2.19

Headlines

Arcturus Therapeutics (NASDAQ ARCT) News Headlines

Source:
DateHeadline
Arcturus Therapeutics Presenting Data for ARCT-810 and the Arcturus mRNA + LUNAR® Technology Platform at the 2019 Annual Meeting of TIDES: Oligonucleotide and Peptide TherapeuticsArcturus Therapeutics Presenting Data for ARCT-810 and the Arcturus mRNA + LUNAR® Technology Platform at the 2019 Annual Meeting of TIDES: Oligonucleotide and Peptide Therapeutics
finance.yahoo.com - May 20 at 10:03 PM
Arcturus Therapeutics (ARCT) Posts  Earnings Results, Misses Estimates By $0.15 EPSArcturus Therapeutics (ARCT) Posts Earnings Results, Misses Estimates By $0.15 EPS
www.americanbankingnews.com - May 14 at 10:21 AM
Arcturus Therapeutics (ARCT) Reports Q1 Loss, Tops Revenue EstimatesArcturus Therapeutics (ARCT) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - May 13 at 7:31 PM
$3.47 Million in Sales Expected for Arcturus Therapeutics Ltd (ARCT) This Quarter$3.47 Million in Sales Expected for Arcturus Therapeutics Ltd (ARCT) This Quarter
www.americanbankingnews.com - May 5 at 8:30 PM
Arcturus Therapeutics Ltd (ARCT) Given Consensus Recommendation of "Buy" by BrokeragesArcturus Therapeutics Ltd (ARCT) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - May 5 at 3:39 PM
-$0.44 Earnings Per Share Expected for Arcturus Therapeutics Ltd (ARCT) This Quarter-$0.44 Earnings Per Share Expected for Arcturus Therapeutics Ltd (ARCT) This Quarter
www.americanbankingnews.com - May 4 at 12:10 AM
Phoenix Molecular Designs Appoints Magda Marquet, Ph.D. to its Board of DirectorsPhoenix Molecular Designs Appoints Magda Marquet, Ph.D. to its Board of Directors
www.prnewswire.com - March 21 at 10:52 AM
Arcturus Therapeutics LtdArcturus Therapeutics Ltd
www.bloomberg.com - March 19 at 7:11 PM
Arcturus Therapeutics Provides Corporate Update and Reports Fourth Quarter and Year End 2018 Financial Results - GlobeNewswireArcturus Therapeutics Provides Corporate Update and Reports Fourth Quarter and Year End 2018 Financial Results - GlobeNewswire
globenewswire.com - March 19 at 9:11 AM
Arcturus Therapeutics Provides Corporate Update and Reports Fourth Quarter and Year End 2018 Financial ResultsArcturus Therapeutics Provides Corporate Update and Reports Fourth Quarter and Year End 2018 Financial Results
finance.yahoo.com - March 18 at 8:40 AM
BRIEF-Arcturus Therapeutics Reassumes Full Worldwide Rights To Arct-810, A Clinical Development Candidate For Ornithine Transcarbamylase DeficiencyBRIEF-Arcturus Therapeutics Reassumes Full Worldwide Rights To Arct-810, A Clinical Development Candidate For Ornithine Transcarbamylase Deficiency
www.msn.com - March 2 at 8:34 AM
Arcturus Therapeutics Appoints Andrew Sassine as Chief Financial Officer - GlobeNewswireArcturus Therapeutics Appoints Andrew Sassine as Chief Financial Officer - GlobeNewswire
globenewswire.com - January 4 at 10:49 AM
Arcturus Therapeutics (ARCT) to Develop ARCT-810 to Treat OTCD - StreetInsider.comArcturus Therapeutics (ARCT) to Develop ARCT-810 to Treat OTCD - StreetInsider.com
www.streetinsider.com - January 3 at 9:01 AM
Arcturus Therapeutics to develop ARCT-810 for treatment of OTCDArcturus Therapeutics to develop ARCT-810 for treatment of OTCD
seekingalpha.com - January 2 at 8:46 AM
Do Insiders Own Lots Of Shares In Arcturus Therapeutics Ltd. (NASDAQ:ARCT)?Do Insiders Own Lots Of Shares In Arcturus Therapeutics Ltd. (NASDAQ:ARCT)?
finance.yahoo.com - December 21 at 5:09 PM
Activists Having Busier-Than-Ever 2018 as Icahn Returns to FrayActivists Having Busier-Than-Ever 2018 as Icahn Returns to Fray
finance.yahoo.com - December 18 at 8:50 AM
MatriSys Bioscience appoints Magda Marquet, PhD to the Board of DirectorsMatriSys Bioscience appoints Magda Marquet, PhD to the Board of Directors
globenewswire.com - November 12 at 8:39 AM
Arcturus Therapeutics Provides Corporate Update and Reports Third Quarter 2018 Financial ResultsArcturus Therapeutics Provides Corporate Update and Reports Third Quarter 2018 Financial Results
finance.yahoo.com - November 7 at 8:51 AM
Is Arcturus Therapeutics Ltd (NASDAQ:ARCT) A Financially Sound Company?Is Arcturus Therapeutics Ltd (NASDAQ:ARCT) A Financially Sound Company?
finance.yahoo.com - October 16 at 4:40 PM
ARCTURUS THERAPEUTICS LTD.ARCTURUS THERAPEUTICS LTD.
www.streetinsider.com - October 2 at 4:38 PM
Arcturus Therapeutics (ARCT) Reports Q2 Loss, Lags Revenue EstimatesArcturus Therapeutics (ARCT) Reports Q2 Loss, Lags Revenue Estimates
www.zacks.com - October 1 at 8:39 AM
Arcturus Therapeutics to Present at October Investor ConferencesArcturus Therapeutics to Present at October Investor Conferences
finance.yahoo.com - September 25 at 8:35 AM
Arcturus Therapeutics Expands Management TeamArcturus Therapeutics Expands Management Team
finance.yahoo.com - September 21 at 8:47 AM
Arcturus Therapeutics Announces Appointment of Ernst & Young LLP as the Companys Independent AuditorArcturus Therapeutics Announces Appointment of Ernst & Young LLP as the Company's Independent Auditor
www.nasdaq.com - August 29 at 4:43 PM
Arcturus Therapeutics Announces Appointment of Ernst & Young LLP as the Company’s Independent AuditorArcturus Therapeutics Announces Appointment of Ernst & Young LLP as the Company’s Independent Auditor
finance.yahoo.com - August 29 at 9:00 AM
Arcturus Therapeutics to Present at Three Investor Conferences in SeptemberArcturus Therapeutics to Present at Three Investor Conferences in September
finance.yahoo.com - August 27 at 9:03 AM
American Rct Reit (ARCT) Achieves Program Milestones, Refines Agreement with Cystic Fibrosis Foundation TherapeuticsAmerican Rct Reit (ARCT) Achieves Program Milestones, Refines Agreement with Cystic Fibrosis Foundation Therapeutics
www.streetinsider.com - July 24 at 9:16 AM
Arcturus Therapeutics Achieves Program Milestones and Refines Agreement with Cystic Fibrosis Foundation TherapeuticsArcturus Therapeutics Achieves Program Milestones and Refines Agreement with Cystic Fibrosis Foundation Therapeutics
finance.yahoo.com - July 23 at 8:37 AM
Arcturus Therapeutics Announces Annual and Extraordinary General Meeting of Shareholders to Be HeldArcturus Therapeutics Announces Annual and Extraordinary General Meeting of Shareholders to Be Held
www.nasdaq.com - July 21 at 8:28 AM
Arcturus Therapeutics Announces Annual and Extraordinary General Meeting of Shareholders to Be Held on August 24, 2018Arcturus Therapeutics Announces Annual and Extraordinary General Meeting of Shareholders to Be Held on August 24, 2018
finance.yahoo.com - July 21 at 8:28 AM
Arcturus Therapeutics Announces Results of Extraordinary General Meeting of ShareholdersArcturus Therapeutics Announces Results of Extraordinary General Meeting of Shareholders
finance.yahoo.com - July 9 at 8:34 AM
Arcturus Therapeutics to Present at the JMP Securities Life Sciences ConferenceArcturus Therapeutics to Present at the JMP Securities Life Sciences Conference
finance.yahoo.com - June 18 at 9:59 AM
WBB Securities Upgrades Arcturus Therapeutics (ARCT) to BuyWBB Securities Upgrades Arcturus Therapeutics (ARCT) to Buy
www.streetinsider.com - June 11 at 4:56 PM
UPDATE: Ladenburg Thalmann Upgrades Arcturus Therapeutics (ARCT) to Buy; Settlement Removes OverhangUPDATE: Ladenburg Thalmann Upgrades Arcturus Therapeutics (ARCT) to Buy; Settlement Removes Overhang
www.streetinsider.com - May 31 at 5:08 PM
American Rct Reit (ARCT) Founder Joseph E. Payne Reinstated as President and CEO; Peter Farrell Named ChairmanAmerican Rct Reit (ARCT) Founder Joseph E. Payne Reinstated as President and CEO; Peter Farrell Named Chairman
www.streetinsider.com - May 31 at 9:01 AM
Arcturus Announces Management Appointments; Company Founder Joseph E. Payne Reinstated as President and CEOArcturus Announces Management Appointments; Company Founder Joseph E. Payne Reinstated as President and CEO
finance.yahoo.com - May 31 at 9:01 AM
Arcturus Appoints Four Directors And Reaches Settlement Deal With Founder PayneArcturus Appoints Four Directors And Reaches Settlement Deal With Founder Payne
www.nasdaq.com - May 29 at 5:01 PM
Arcturus Therapeutics Appoints Four New Directors and Reaches Settlement Agreement with Founder Joseph E. PayneArcturus Therapeutics Appoints Four New Directors and Reaches Settlement Agreement with Founder Joseph E. Payne
finance.yahoo.com - May 29 at 8:44 AM
Arcturus Therapeutics Founder Joseph Payne Calls for an End to Company’s Frivolous and Costly Lawsuits; Applauds Court Decision and Welcomes June 25, 2018 EGM DateArcturus Therapeutics Founder Joseph Payne Calls for an End to Company’s Frivolous and Costly Lawsuits; Applauds Court Decision and Welcomes June 25, 2018 EGM Date
finance.yahoo.com - May 23 at 8:41 AM
Arcturus Therapeutics Founder Joseph Payne Welcomes Court Decision to Set Date and Agenda of Extraordinary ...Arcturus Therapeutics Founder Joseph Payne Welcomes Court Decision to Set Date and Agenda of Extraordinary ...
globenewswire.com - May 16 at 5:07 PM
Arcturus Therapeutics Files Form 20-FArcturus Therapeutics Files Form 20-F
finance.yahoo.com - May 15 at 9:07 AM
Arcturus Therapeutics Founder Joseph Payne Welcomes Court Decision to Set Date and Agenda of Extraordinary General Meeting to Vote for New Board MembersArcturus Therapeutics Founder Joseph Payne Welcomes Court Decision to Set Date and Agenda of Extraordinary General Meeting to Vote for New Board Members
finance.yahoo.com - May 14 at 5:00 PM
Arcturus Therapeutics Founder Joseph Payne Successfully Prevents Boards Egregious Attempt to Dilute ShareholdersArcturus Therapeutics Founder Joseph Payne Successfully Prevents Board's Egregious Attempt to Dilute Shareholders
globenewswire.com - May 3 at 4:58 PM
BRIEF-Amir Efrati Reports 5.3 Percent Stake In Arcturus TherapeuticsBRIEF-Amir Efrati Reports 5.3 Percent Stake In Arcturus Therapeutics
www.reuters.com - May 1 at 8:53 AM
Blog Exposure - Arcturus Initiates Lawsuit against Former CEO Joseph Payne for Misconduct and Violations of Federal DisclosureBlog Exposure - Arcturus Initiates Lawsuit against Former CEO Joseph Payne for Misconduct and Violations of Federal Disclosure
finance.yahoo.com - April 24 at 5:13 PM
BRIEF-Joseph Payne Says "Rejects" Arcturus Therapeutics Board Of Directors Latest Lawsuit Against PayneBRIEF-Joseph Payne Says "Rejects" Arcturus Therapeutics' Board Of Directors' Latest Lawsuit Against Payne
www.reuters.com - April 23 at 4:54 PM
Arcturus Therapeutics Founder Joseph Payne Dismisses Board’s Baseless Lawsuit as Desperate Entrenchment TacticArcturus Therapeutics Founder Joseph Payne Dismisses Board’s Baseless Lawsuit as Desperate Entrenchment Tactic
finance.yahoo.com - April 23 at 4:54 PM
Arcturus Therapeutics Files Lawsuit Against Joseph E. Payne and His Associates for Violations of Federal Securities ...Arcturus Therapeutics Files Lawsuit Against Joseph E. Payne and His Associates for Violations of Federal Securities ...
globenewswire.com - April 20 at 5:00 PM
BRIEF-Arcturus Therapeutics Files Lawsuit Against Former CEO Joseph Payne And His AssociatesBRIEF-Arcturus Therapeutics Files Lawsuit Against Former CEO Joseph Payne And His Associates
www.reuters.com - April 20 at 8:56 AM
BRIEF-Joseph Payne Sent Letter To Arcturus Board To Restate Prior Demand To Convene EGMBRIEF-Joseph Payne Sent Letter To Arcturus Board To Restate Prior Demand To Convene EGM
www.reuters.com - April 19 at 8:46 AM
This page was last updated on 5/27/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel